entertainment -WSS

entertainment

author：comprehensive 2025-09-29 20:53:04 - browse：31

Eli Lilly headquarters — Kristoffer Tripplaar/AP

Eventually, the luckiest companies get to deal with a very particular problem: what to do when their stock could be getting ahead of itself.

It’s a problem Eli Lilly got a little taste of Tuesday when it announced its full-year earnings. The drugmaker’s stock has more than doubled over the past 12 months due to the ever-increasing hopes for its GLP-1-based diabetes and weight loss drug, sold under the brand names Mounjaro and Zepbound. It was a big deal when Lilly became the first drug company ever to have a market value of $500 billion; it’s now sitting at a stunning $670 billion.

At first, the earnings report suggested the company had blasted through expectations again, announcing fourth-quarter 2023 sales of $9.35 billion, almost half a billion dollars above analysts’ expectations, and also announcing new data for Mounjaro in treating metabolic dysfunction-associated steatohepatitis (MASH), a form of liver disease previously called NASH. Initially, shares traded up 5%.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： How to convince healthy people to buy insurance

hotspot

WSS

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Lung cancer screening guidelines updated for cigarette smokers

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Chris Christie meets with Zelenskyy during Ukraine trip

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

Prime Medicine says its gene editing passes test in monkeys

Wikipedia

entertainment

explore

Jerome Adams on the need for new antivirals for Covid

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Medicare details structure of new drug price negotiation program

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

FDA scientists endorse Pfizer/BioNTech Covid

Affirmative action in medical school literally saved lives

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

At least 13 dead in Texas as scorching temps continue

Infant mortality in U.S. rose last year for first time in decades: CDC

focus

Flint parents haunted by uncertainty, fears of lead poisoning

How to ethically and practically extend health care to all

Life sciences investors close nearly $6 billion in new funds

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Medicare slashes safety net hospital payments by nearly $1 billion

The cancer stories no one wants to hear

hotspot

explore

hotspot

Wikipedia